Science Explorer Back to mapMap
Discussion
Topic · Neurology

Peripheral Neuropathies and Disorders

Peripheral Neuropathies and Disorders is a research topic within Neurology. Science Explorer counts 27k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on Guillain-Barré syndrome and related neuropathies, including chronic inflammatory demyelinating polyradiculoneuropathy. It covers the pathogenesis, diagnosis, treatment, and prognosis of these neurological disorders, with a particular emphasis on the role of intravenous immunoglobulin therapy. The cluster also explores the autoimmune nature of these neuropathies and their association with specific antibodies and infections.

  • Guillain-Barré Syndrome
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  • Neurological Disorders
  • Autoimmune Neuropathies
  • Polyneuropathy
  • Intravenous Immunoglobulin
  • Pathogenesis
  • Diagnosis
  • Treatment
  • Prognosis
Research works
27k
fractional, since 1950
In the world top 10%
2.7k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+18%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Peripheral Neuropathies and Disorders

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Peripheral Neuropathies and Disorders research?

By volume, the United States and China publish the most (1.2k and 616 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.2k works
  2. 2 China 616 works
  3. 3 India 440 works
  4. 4 Japan 370 works
  5. 5 Italy 291 works
  6. 6 United Kingdom 269 works
  7. 7 Germany 260 works
  8. 8 France 231 works
  9. 9 Spain 189 works
  10. 10 Türkiye 163 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.5%China: 15.1%India: 10.8%Japan: 9.1%6 others listed: 34.4%30%largest
United States1,242 · 30.5%China616 · 15.1%India440 · 10.8%Japan370 · 9.1%6 others listed1,402 · 34.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Peripheral Neuropathies and Disorders research?

By volume in 2022-now, Mayo Clinic publishes the most Peripheral Neuropathies and Disorders research, followed by Harvard University and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 62 works
  2. 2 Harvard UniversityUnited States 51 works
  3. 3 All India Institute of Medical SciencesIndia 43 works
  4. 4 University College LondonUnited Kingdom 42 works
  5. 5 Capital Medical UniversityChina 32 works
  6. 6 InsermFrance 31 works
  7. 7 The University of SydneyAustralia 26 works
  8. 8 Johns Hopkins UniversityUnited States 24 works
  9. 9 Centre National de la Recherche ScientifiqueFrance 22 works
  10. 10 University of TorontoCanada 22 works

Who are the leading researchers in Peripheral Neuropathies and Disorders?

The most-cited researchers publishing on Peripheral Neuropathies and Disorders include Cyrus Cooper, Graeme J. Hankey and Richard A. Gibbs.

  1. 1 Cyrus Cooper United Kingdom 342k citations
  2. 2 Graeme J. Hankey Australia 316k citations
  3. 3 Richard A. Gibbs United States 292k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Peripheral Neuropathies and Disorders?

The most cited paper in Peripheral Neuropathies and Disorders is "Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria" (Alan J. Thompson et al., 2017), with 8,265 citations. Next come "Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis" (6,993) and "Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”" (5,023).

Most cited papers
#PaperReleasedCitations
1 Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J. Thompson et al. · The Lancet Neurology Open access 21 Dec 2017 8,265
2 Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology 26 Jun 2001 6,993
3 Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” Chris H. Polman, Stephen C. Reingold, Gilles Edan et al. · Annals of Neurology Open access 10 Nov 2005 5,023
4 International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al. · Neurology Open access 19 Jun 2015 4,664
5 A clinical approach to diagnosis of autoimmune encephalitis Francesc Graus et al. · The Lancet Neurology Open access 20 Feb 2016 4,550
All 99 most cited papers, with filters and sorting

Where is Peripheral Neuropathies and Disorders research done?

The largest centres of Peripheral Neuropathies and Disorders research in 2022-now are Beijing (China), London (United Kingdom), Tokyo (Japan) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester and Scottsdale.

Largest cities, 2022-now

  1. 1 BeijingChina 99 works
  2. 2 LondonUnited Kingdom 96 works
  3. 3 TokyoJapan 93 works
  4. 4 ParisFrance 82 works
  5. 5 SeoulSouth Korea 66 works
  6. 6 IstanbulTürkiye 55 works
  7. 7 RomeItaly 54 works
  8. 8 New YorkUnited States 53 works
  9. 9 TehranIran 52 works
  10. 10 MoscowRussia 48 works

Where it is the local speciality

  1. RochesterUS · 23.8 works9.7×
  2. ScottsdaleUS · 24.6 works8.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Peripheral Neuropathies and Disorders than the world average.

See Peripheral Neuropathies and Disorders on the map

Where is the best place to study Peripheral Neuropathies and Disorders?

Among universities, judged by research, University College London, Harvard University and University of Oxford score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 23.69%fractional works in this field (log) →share of work in the world top 10% →University of OxfordMedical University o…University College L…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University College LondonUnited Kingdom 78.221.6%4.8×42 +5.5%
2Harvard UniversityUnited States 70.917.4%2.9×51 +5.7%
3University of OxfordUnited Kingdom 70.426.2%2.6×20 +7.5%
4Medical University of ViennaAustria 64.822.3%9.2×16 +2.6%
5Erasmus University RotterdamNetherlands 63.629.0%4.5×13 -11.7%
6National and Kapodistrian University of AthensGreece 63.128.2%5.0×14 +30.0%
7Universitat Autònoma de BarcelonaSpain 62.729.0%3.9×14 +8.3%
8Humboldt-Universität zu BerlinGermany 61.926.6%4.4×9 +86.9%
9Johns Hopkins UniversityUnited States 61.417.4%2.8×24 +3.7%
10The University of SydneyAustralia 59.819.2%3.9×26 -7.2%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Peripheral Neuropathies and Disorders, country by country

Is Peripheral Neuropathies and Disorders research growing?

Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Peripheral Neuropathies and Disorders.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Peripheral Neuropathies and Disorders as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%Peripheral Neuropathies and Disorders0.025% in 202519801990200020102020

Fractional works of Peripheral Neuropathies and Disorders over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Peripheral Neuropathies and Disorders9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Peripheral Neuropathies and Disorders. Posts are plain text and can be reported.